Navigation Links
Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Date:4/20/2012

EAST BRUNSWICK, N.J., April 20, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the Company's first quarter financial results will be released prior to the open of the market on Wednesday, May 9, 2012.
Savient executive management will host a conference call beginning at 9:00 a.m. Eastern Time on May 9, 2012, to discuss these results and to answer questions.

To participate by telephone, please dial 866-393-1565 (Domestic) or 253-237-1151 (International). The conference ID number is 72346185.  The live and archived webcast can be accessed on the investor relations section of the Savient website at www.savient.com.  A telephone replay will be available from 12:00 p.m. Eastern Time on May 9, 2012, through 12:00 a.m. Eastern Time on May 16, 2012, by dialing 855-859-2056 (Domestic) or 404-537-3406 (International) and entering conference ID number 72346185.

ABOUT SAVIENT PHARMACEUTICALS, INC.Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University ("Duke") and Mountain View Pharmaceuticals, Inc. ("MVP"). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA. Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company's website at www.savient.com.

SVNT-IContact: Mary Coleman

Carney Noensie Savient Pharmaceuticals, Inc.

Burns McClellan information@savient.com

cnoensie@burnsmc.com (732) 418-9300

(212) 213-0006


'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Imperial Capital Healthcare Investor Forum
2. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2011 Results
3. Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Savient Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference
5. Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
6. Savient Pharmaceuticals Appoints Experienced Pharmaceutical Executive, David Veitch as President of Savient Europe
7. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
8. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
9. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
10. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
11. Savient Pharmaceuticals to Hold Third Quarter 2011 Financial Results Conference Call on Thursday, November 3, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... ... February 19, 2020 , ... ... for research data management, has released a new SnapGene integration. ... features. With a ‘Quick View’ of supported DNA files, the molecular biology ...
(Date:2/19/2020)... ... 19, 2020 , ... Global Healthcare Exchange, LLC ... of its annual GHX “Best 50” supply chains in North America. ... ability to demonstrate improved operational performance and drive down costs through supply chain ...
(Date:2/16/2020)... ... February 16, 2020 , ... In Partnership with the Smiles ... at its Kennewick, WA office. , A limited number of appointments are available, but ... For more information or to schedule an appointment, please call (509)-820-4302. , Who: Bright ...
Breaking Medicine Technology:
(Date:2/21/2020)... ... 2020 , ... Representatives with Bay-Bay Water today announced that the company has launched ... company logo as part of the ongoing evolution of our company’s brand,” said Osmay Gonzalez, ... company is expanding its national reach. , “We have refreshed our logo to reflect who ...
(Date:2/20/2020)... (PRWEB) , ... February 20, 2020 , ... R3 Medical ... Las Vegas Nevada. Providers will learn how to perform injections for all large and ... not easy to learn from online videos. The best opportunity is to perform injections ...
(Date:2/19/2020)... ... February 19, 2020 , ... Drs. Richard Amato, Michael Kang, ... Connecticut, celebrate 30 years of serving Monroe, CT with a “Throwback Special” where ... charged in 1989, only thirty dollars. To further serve their patients, they published ...
(Date:2/19/2020)... Mass. (PRWEB) , ... February 19, 2020 , ... ... the quality and consistency of healthcare delivery, announced that it will participate in ... 2020, in Orlando, Florida. BPM+ Health will engage healthcare professionals and other stakeholders ...
(Date:2/16/2020)... ... February 16, 2020 , ... Canadian digital healthcare portal Ask The Doctor ... are concerned about the Coronavirus. , "It is our duty and it is our ... deadly virus" said Prakash Chand, CEO of Ask The Doctor. , Doctors and nurses ...
Breaking Medicine News(10 mins):